Saeed Motahari, President & CEO at Insys Therapeutics, Inc. (INSY), bought 4,500 shares at $11.98 ($54K) on 2017-05-16, disclosed to the SEC on 2017-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |